|
|
||||||||
Departments of 1 Cardiology and 2 Medical Physics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
| |
ABSTRACT |
|---|
|
|
|---|
Pressure-based fractional flow
reserve (FFR) is used clinically to evaluate the functional severity of
a coronary stenosis, by predicting relative maximal coronary flow
(Qs/Qn). It is considered to be independent of
hemodynamic conditions, which seems unlikely because stenosis
resistance is flow dependent. Using a resistive model of an epicardial
stenosis (0-80% diameter reduction) in series with the coronary
microcirculation at maximal vasodilation, we evaluated FFR for changes
in coronary microvascular resistance (Rcor = 0.2-0.6 mmHg · ml
1 · min), aortic
pressure (Pa = 70-130 mmHg), and coronary outflow pressure (Pb = 0-15 mmHg). For a given stenosis,
FFR increased with decreasing Pa or increasing
Rcor. The sensitivity of FFR to these
hemodynamic changes was highest for stenoses of intermediate severity.
For Pb > 0, FFR progressively exceeded
Qs/Qn with increasing stenosis severity unless
Pb was included in the calculation of FFR. Although the
Pb-corrected FFR equaled Qs/Qn for
a given stenosis, both parameters remained equally dependent on
hemodynamic conditions, through their direct relationship to both
stenosis and coronary resistance.
coronary artery stenosis; coronary circulation; coronary stenosis evaluation; coronary flow reserve
| |
INTRODUCTION |
|---|
|
|
|---|
WITH THE INTRODUCTION of sensor-tipped guide wires, physiological parameters are increasingly used to assess coronary stenosis severity in functional terms. Pressure-based fractional flow reserve (FFR) has rapidly developed into a frequently used parameter to identify clinically relevant stenoses and to serve as a basis for evaluating the success of coronary interventions (6, 35). The established cutoff value for FFR is 0.75, which implies that the stenosis is considered significant when distal pressure during maximum hyperemia is <75% of aortic pressure and otherwise is not significant (33). FFR is considered to be independent of hemodynamic conditions (8, 15, 32-34), although it has been pointed out that the flow dependence of stenosis resistance is hardly compatible with such a conclusion (13).
Conceptually, FFR derives from pressure-flow relations of the stenosed epicardial vessel and of the coronary circulation at full vasodilation. A number of physiological studies have demonstrated that external hemodynamic conditions affect coronary pressure-flow relations at maximum vasodilation (21). Similarly, it is well known that stenosis resistance depends on flow because of the quadratic relation between pressure loss and flow rate due to the Bernoulli effect (49). Hence, extrapolation of these findings would predict a dependence of FFR on physiological conditions that alter coronary flow, such as aortic pressure or coronary vascular bed resistance (17).
To systematically assess the individual impact of different hemodynamic circumstances on the value of FFR as derived from intracoronary pressure signals, we carried out this parametric study based on the model underlying the concept of FFR.
| |
METHODS |
|---|
|
|
|---|
Description of model.
The coronary circulation was modeled as a flow-dependent stenosis
resistance in series with a lumped downstream coronary resistance (Fig.
1A). At maximum vasodilation
and in the absence of a stenosis, the coronary pressure-flow relation
can be approximated, within limits, by a straight line with a positive
intercept on the pressure axis, denoted here as Pb, which
is a few millimeters of mercury higher than venous pressure
(Pv) (3, 21). Hence, a change in flow (Q) is
proportional to a change in perfusion pressure (Pa) (Fig.
1B). In this model we defined the inverse of this
slope as coronary microvascular resistance during maximal vasodilation (Rcor), in accordance with the model originally
presented by Pijls et al. (36). This model resistance,
together with Pb, correctly describes the physiological
pressure-flow line over a wide range of pressures. Because of the
incremental-linear nature of the coronary pressure-flow line, a model
with coronary resistance equal to the inverse of the slope of this line
is allowed only if Pb is subtracted from the perfusion
pressure, whereas coronary resistance defined as P/Q or (P
Pv)/Q is pressure dependent (Fig. 1B; Refs.
22, 45). Given these considerations, the
following relations hold for the model shown in Fig. 1A
during maximum vasodilation
|
(1) |
|
(2) |
|
(3) |
Ps is the pressure gradient across stenosis,
Av is the coefficient for viscous pressure
losses along the stenosis, and B is the coefficient for
inertial pressure losses at the exit of the stenosis.
|
|
(4) |
|
(5) |
|
(6) |
Model parameters.
The stenosis was modeled as a blunt-shaped, rigid obstruction in a
noncompliant vessel with a 3-mm diameter. Stenosis severity was varied
between 0% and 80% diameter reduction with a length of 6 mm. The
hemodynamic parameters were chosen in variations about a normal value.
Coronary resistance at maximum vasodilation was varied from 0.2 to 0.6 mmHg · ml
1 · min, with 0.4 mmHg · ml
1 · min representing control
conditions. Outflow pressure Pb was used at values of 0, 10 (control), and 15 mmHg. To illustrate the potential effect of advanced
diseased states, we also modeled pathophysiological examples with a
threefold increase in Rcor (1.8 mmHg · ml
1 · min) and Pb (45 mmHg). Flow rate was varied as the independent variable from 0.1 to 600 ml/min, resulting in perfusion pressures Pa between
Pb and 200 mmHg. The resulting values for FFR were then
interpolated to obtain data at aortic pressures of 70 and 130 mmHg for
each combination of Pb and Rcor. All
dimensionless variables are presented without indication of units of measurement.
| |
RESULTS |
|---|
|
|
|---|
Table 1 lists the calculated
pressure loss coefficients Av and B
that were used to determine the pressure drop for each stenosis model
according to Eq. 3. The resulting curvilinear pressure
drop-flow relationships are shown in Fig.
2A. Stenosis resistance
increased with increasing flow rate (Eq. 4), as reflected by
the increasing slope of the curve for each stenosis. Corresponding
coronary pressure-flow lines of the stenosed coronary circulation at
full vasodilation are shown in Fig. 2B for the control
case of Rcor = 0.4 mmHg · ml
1 · min and Pb =10
mmHg. The slope of each curve decreased with increasing pressure
because of the rising stenosis resistance Rs in
series with Rcor (Fig. 1A). The
maximum flow without a stenosis was 224 ml/min at a perfusion pressure
of 100 mmHg and decreased with increasing stenosis severity to ~43
ml/min for the 80% diameter stenosis. At Pa = 130 mmHg, maximal flow increased to 299 ml/min without a stenosis and 53 ml/min for the 80% stenosis.
|
|
Results for the uncorrected FFR (= Pd/Pa;
Eq. 6) are shown in Fig. 3 for
the same control conditions (Rcor = 0.4 mmHg · ml
1 · min and Pb =10
mmHg). The pressure ratio Pd/Pa was only
independent of aortic pressure for a vessel without a stenosis (Fig.
3A). With increasing stenosis severity,
Pd/Pa decreased progressively with increasing
aortic pressure. Between 70 and 130 mmHg, Pd/Pa decreased by 0.004 for the 20% stenosis but by 0.105 for the 65% stenosis. The 60% stenosis crossed the cutoff value of 0.75 because of
this change in perfusion pressure. The dependence of
Pd/Pa on perfusion pressure is mediated by the
flow dependence of stenosis resistance. The role of this flow
dependence becomes clearer in Fig. 3B, where the same
results are shown as a function of changes in flow, calculated by
varying perfusion pressure at constant Rcor. Two
isobars are drawn at perfusion pressures of 70 and 130 mmHg. Moving on
a curve from one isobar to the other demonstrates that the increase in
flow resulting from a fixed increase in perfusion pressure is
diminished with increasing stenosis severity (see also Fig.
2B) but that changes in Pd/Pa are
smallest at low stenosis severities.
|
The sensitivity of Pd/Pa to changes in
hemodynamic conditions in terms of coronary resistance, coronary
outflow pressure, and aortic pressure is shown in Fig.
4 as a function of stenosis severity.
Results are shown for the total range of hemodynamic changes modeled in
this study.
|
Figure 4A depicts the nonlinear decrease of
Pd/Pa with increasing stenosis severity at
Pb = 0 mmHg. For a specific stenosis, however,
Pd/Pa was a function of the modeled hemodynamic
conditions. An increase in Rcor from 0.2 to 0.6 mmHg · ml
1 · min caused a substantial
increase in Pd/Pa for stenosis severities of
greater than 20% diameter reduction. This trend continued at a lower
rate for a further increase of Rcor to 1.8 mmHg · ml
1 · min (Fig. 4A). At
a constant Rcor, a decrease in Pa
from 130 to 70 mmHg resulted in an increase in
Pd/Pa for a given stenosis. Note that
Pd/Pa for lesions of intermediate severity
crossed the cutoff value because of changes in Pa or
Rcor. The stenosis severity required to cross
the cutoff value increased with increasing Rcor.
The magnitudes of changes induced by these altered hemodynamic
conditions are illustrated in Fig. 4B in absolute
(Fig. 4B, left) and relative (Fig. 4B,
right) terms. For Rcor between 0.2 and 0.6 mmHg · ml
1 · min, absolute
changes in Pd/Pa were largest for intermediate lesions between 40% and 70% diameter reduction, reaching a
maximal value of 0.34. With Rcor increasing even
further, the maximum sensitivity to hemodynamic changes shifted to
higher stenosis severities (Fig. 4B, dashed lines). The
maximum absolute change in Pd/Pa was on the
order of 0.08 for a decrease in Pa from 130 to 70 mmHg.
Because the FFR for intermediate lesions is close to the clinical
threshold of 0.75 (Fig. 4A), prevailing hemodynamic conditions can introduce a significant margin of error in clinical decision-making.
Figure 4C illustrates that an increase in Pb to
15 mmHg caused an increase in Pd/Pa compared
with the corresponding values at Pb = 0 mmHg. The
sensitivity to a change in Pb increased with stenosis
severity and was higher when Rcor was low,
reaching maximal values on the order of 0.2 (Fig. 4C,
left). Compared with the data obtained at
Pb = 0 mmHg (Fig. 4B, left), the
modeled response to lowering Pa increased by ~62% for
intermediate stenoses, reaching values on the order of 0.13, whereas
the response to changing Rcor was slightly
reduced by 12%. A further rise in Pb to a
pathophysiological value of 45 mmHg amplified the increase in
Pd/Pa by approximately a factor of 3 as shown
by the dashed curve in Fig. 4C for the example of
Rcor =0.2
mmHg · ml
1 · min at Pa = 130 mmHg. Relative differences from values at Pb = 0 mmHg rose rapidly for stenoses greater than 40% diameter reduction (Fig. 4C, right).
Figure 5A illustrates the
effect of changes in hemodynamic parameters on the relationship between
FFR and Qs/Qn for the case of
Rcor = 0.2 mmHg · ml
1 · min. When
Pb > 0 (15 mmHg in this example) and FFR was not corrected for Pb (FFR = Pd/Pa;
Eq. 6), the relative maximal flow, Qs/Qn, was progressively overestimated with
increasing stenosis severity (Fig. 5A, top 2 regression
lines). In that case, the relationship between FFR and
Qs/Qn became dependent on Pa, with a larger overestimation at lower perfusion pressures. An increase of
Pb to 45 mmHg aggravated the overestimation by about a
factor of 3, with the data points and corresponding regression lines rotating clockwise around the upper right point representing no stenosis (not shown here). The relationships were independent of
coronary resistance, but for higher values of
Rcor both FFR and Qs/Qn
increased (see Fig. 4A) and corresponding data points for a
given stenosis shifted to higher values on their respective regression
lines (not shown here for clarity). Consequently, the percent
overestimation for a given stenosis became lower, as shown in Fig.
5B for the case of Pa = 130 mmHg.
|
With Pb = 0 mmHg (Fig. 5A), the relationships became equal to the line of identity and Pd/Pa matched Qs/Qn. Similarly, when FFR was calculated by including a nonzero Pb (Eq. 5), the data were also brought to the line of identity and FFR was equal to Qs/Qn (Fig. 5A). However, equivalence between FFR and Qs/Qn did not imply that Pa or Pb no longer had an influence. Changes in hemodynamic conditions affected both FFR and Qs/Qn to the same degree, shifting individual data points for a given stenosis along the line of identity. Note that the values at Pb = 0 and Pb= 15 mmHg (Eq. 5) are different because of differences in flow through the stenosis. Boxes around the data for a specific stenosis in Fig. 5A indicate the range of changes in corresponding values of FFR and Qs/Qn obtained for the hemodynamic conditions shown here.
| |
DISCUSSION |
|---|
|
|
|---|
This parametric model study demonstrates, based on realistic pressure-flow relations of a fixed stenosis in an epicardial artery and of the coronary circulation at maximum vasodilation, that the FFR for a given stenosis is influenced by arterial input pressure, the slope of the coronary pressure-flow line at maximal vasodilation, and coronary outflow pressure. These parameters change flow through the stenosed artery, which has a nonlinear effect on the pressure distal to the stenosis and, therefore, on the ratio of distal to proximal pressure, commonly used to represent FFR.
Equivalence of FFR and relative maximal flow
Qs/Qn.
In 1977 Young et al. (50) proposed the stenosis-induced
relative reduction of maximally possible flow to a vascular bed, Qs/Qn, as a useful index for characterizing the
effect of a stenosis. The concept of myocardial FFR was developed with
the purpose of quantifying this index for the myocardial vascular bed
on the basis of pressure measurements proximal and distal to the
stenosis. The equivalence of the pressure-based and flow-based ratios
has been demonstrated on the basis of a theoretical model in which stenosis resistance was assumed to be constant (32,
34-36). It is important to note that our model confirms
this equivalence, taking into account the flow dependence of stenosis
resistance, but only when the outflow pressure Pb is
included in the calculation, as FRR = (Pd
Pb)/(Pa
Pb). The assumption
that Pb is equal to zero introduces an overestimation of
FFR = Pd/Pa with respect to the flow ratio
Qs/Qn, whose magnitude depends on the aortic pressure and coronary resistance at the time of measurement and is
proportional to the actual outflow pressure. As explained below, this
overestimation exists regardless of the presence or absence of
collateral flow.
Justification of pressure-flow relations and parameters. The range of mean aortic pressures used in this model (70-130 mmHg) reflects the range of experimental and clinical studies (8, 15, 36). The equation used to describe the pressure drop-flow relationship of the coronary stenosis (Eq. 3) is solidly based on hemodynamic theory and has been extensively validated with stenosis models in tubes and arteries (26, 49, 50). Coronary stenosis pressure drop-flow velocity relations in vivo show the same behavior (14, 40). Obviously, the exact shape of the curve depends on detailed geometric and biomechanical properties of the stenosis (24, 42), but the quadratic component between pressure gradient and flow is a fundamental characteristic.
In accordance with the original model proposed by Pijls et al. (36), we used the inverse of the slope of the coronary pressure-flow relation at maximum vasodilation as a measure of coronary microvascular resistance. This definition of coronary resistance is model based and should be interpreted with caution, because all vessels are compliant, rendering microvascular resistance inherently pressure dependent. This is why the coronary pressure-flow line exhibits concave curvature in the low-pressure range (11, 16, 18, 46). However, pragmatically, the pressure-flow relation can be approximated over the range of physiologically and clinically relevant pressures by a straight line, intercepting the pressure axis at a pressure denoted as Pb in this study. In this context, it is important to note that, irrespective of the constant slope of the pressure-flow line, coronary microvascular resistance calculated as distal perfusion pressure divided by flow is indeed pressure dependent, leading to higher values at lower distal pressures downstream of severe stenoses (see Fig. 1B; Ref. 37). The initial slope of our coronary pressure-flow relation without a stenosis follows from a realistic coronary blood flow of 224 ml/min under conditions of maximum vasodilation. This value compares well with maximal regional myocardial blood flow for 80-100 g of tissue measured in healthy volunteers or in regions supplied by minimally stenosed arteries (10, 47, 48). The range we evaluated (±0.2 mmHg · ml
1 · min, or ±50%)
reflects the variation found for normal hearts and patients with
coronary artery disease (28, 48) but also the variation
between different perfusion areas of the same heart (7).
Left ventricular hypertrophy, ischemia, infarction,
microvascular disease (5, 12, 25, 47), and acute changes
in contractility or heart rate (11, 37) also affect
minimum coronary resistance to a degree comparable to the range modeled
in this study. The resulting range of values for FFR compares well to
that obtained in an unselected patient cohort (2) and to
data obtained in dogs (15) for similar stenosis degrees.
The highest value of 1.8 mmHg · ml
1 · min
was chosen to illustrate the direction of outcomes for a large decrease
in coronary conductance, e.g., caused by severe microvascular dysfunction.
The in vivo value of Pb at maximum vasodilation exceeds
coronary venous pressure by a few millimeters of mercury (18,
21). From physiological studies in dogs and swine one finds
values on the order of 10-15 mmHg in normal beating hearts
(4, 31) but as high as 40 mmHg in hypertrophy (11,
12). Moreover, it has been demonstrated that Pb
depends on factors such as left ventricular filling pressure, heart
rate, and contractility (11, 19). Hence, the normal range
we studied, 0-15 mmHg, is quite realistic, with an extreme value
of 45 mmHg chosen to elucidate the potential effect of severe left
ventricular hypertrophy.
Comparison with experimental studies. Our findings on the pressure dependence of FFR appear to be at odds with earlier reports, which suggest that FFR is rather independent of hemodynamic conditions (8, 15, 36, 38). Gould et al. (15) critically demonstrated the importance of using relative maximal flow Qs/Qn, denoted as relative flow reserve, over absolute coronary flow reserve in that the latter was more dependent on aortic pressure. However, their results of relative maximal flow for the intermediate stenosis range demonstrated sufficient variability (e.g., Qs/Qn = 0.42 ± 0.18, or 43% change for a 61% diameter stenosis) with a change in aortic pressure from 70 to 150 mmHg to be consistent with our model predictions.
Pijls et al. (36) compared FFR, calculated by including Pb (Eq. 5), with the relative maximal flow velocity (Qs/Qn), measured directly by a Doppler transducer proximal to the stenosis, in dogs at three different levels of aortic pressure, ranging from an average of 56 to 113 mmHg. They found an excellent correlation of Qs/Qn with the pressure-derived values of relative maximal flow, which confirmed the validity of the underlying equations (36) and is consistent with our results shown in Fig. 5A. However, the stenosis degrees in their study were not the same at different pressures and, therefore, the data did not allow inferences about pressure dependence of FFR for a given stenosis. As discussed above, a change in aortic pressure affects both the relative maximal flow for a given stenosis and the corresponding pressure ratio representing FFR and all points fall on one line. As shown in the study by Pijls and coworkers (36), this is the line of identity when collateral flow is absent and a line with a positive intercept when collateral flow is present. These important studies solidly established the principles of the applicability of FFR to predict relative maximal flow but did not conclusively demonstrate an independence of FFR from hemodynamic conditions for a given stenosis. Others also based their conclusion of FFR being independent of aortic pressure on the relationship between FFR and Qs/Qn, using data obtained in a mock circulation system (38) or misinterpreting results obtained in the earlier animal studies (32, 33, 35). However, as discussed above, the FFR vs. Qs/Qn relationship is not suited for drawing conclusions on the hemodynamic independence of FFR for a specific stenosis. In a clinical study, De Bruyne et al. (8) focused on the dependence of FFR on hemodynamic conditions for a given stenosis by comparing data before and after a change in heart rate, aortic pressure, or contractility. Stenosis severities ranged from 21% to 66% diameter reduction. A change in heart rate or contractility did not result in a significant change in mean aortic pressure, blood flow velocity, or pressure gradient during maximal vasodilation, and, consequently, average Pd/Pa did not change either. When aortic pressure was lowered by an average of 20 mmHg, Pd/Pa also did not change significantly, despite a significant reduction in maximal blood flow velocity. However, as noted by the authors, interaction of hemodynamic effects could not be avoided in this patient study. A reflex tachycardia was induced, which most likely reduced left ventricular end-diastolic pressure, thereby decreasing Pb. Because FFR in this study was calculated assuming Pb = 0 mmHg (FFR = Pd/Pa, Eq. 6), an undetected decrease in Pb could have masked the effect of lowering arterial pressure on Pd/Pa. In our study, values of Pd/Pa at Pb = 15 mmHg and Pa = 130 mmHg differed <5% from those at Pb = 0 mmHg and Pa = 70 mmHg for stenoses less than 70% in diameter reduction. Hence, if Pb and Pa both change in the same direction, Pd/Pa may stay almost constant. The same is true for an appropriate combination of changes in perfusion pressure and coronary resistance.Why is FFR dependent on hemodynamic conditions?
The interpretation of the experimental studies and our model results
may be simplified by expressing the maximal flow ratio (Eq. 5) as
|
(7) |
Pb). Maximal flow in the presence
of an epicardial stenosis therefore increases nonlinearly with
increasing perfusion pressure (Fig. 2B), and
Qs/Qn is no longer independent of aortic
pressure. This flow-dependent behavior of FFR has been demonstrated
both in vivo (50) and in vitro (27). It
follows from Eq. 7 that FFR crosses the threshold value of
0.75 when stenosis resistance becomes greater than 33% of coronary
microvascular resistance. The combined influence of hemodynamic changes
on FFR depends on their relative effect on Rs
and Rcor.
Critique of model. In the development of this model, we have used fundamental fluid dynamic and physiological principles to describe the pressure-flow relations of the diseased coronary circulation. Our study aimed to quantify the hemodynamic dependence of FFR on a theoretical basis by independent variation of individual physiological parameters. However, hemodynamic changes in vivo rarely occur in isolation and may combine to amplify or reduce the overall effect. As discussed above and consistent with our model, FFR may appear constant in vivo despite altered hemodynamic conditions (8, 44), depending on the combination and magnitude of hemodynamic changes.
Because we wanted to focus on the effect of hemodynamic changes on relative maximal flow in a stenosed vessel, we did not include collateral flow in our model. The presence of a collateral circulation has two related effects: total flow to the myocardium is higher than flow through the stenosed vessel alone, and myocardial FFR (Eq. 5) is therefore higher than the relative maximal flow Qs/Qn through the stenosed vessel alone. The addition of collateral flow to our model would affect our results only insofar as the effect of a flow-dependent stenosis resistance on myocardial FFR is diminished by the relative contribution of collateral flow to total coronary flow at maximal vasodilation. With the linear inverse relation between fractional collateral flow and Qs/Qn, data for intermediate lesions (FFR = 0.75) can be derived from the animal study by Pijls et al. (36) and an average 12.6% of total myocardial flow. Even for severe lesions (mean diameter reduction = 74-84%, mean FFR = 0.53-0.64), collateral flow was shown to contribute only between 13% and 33% of total coronary flow at maximal vasodilation in humans (39), depending on the degree of collateral development. Assuming that the collateral contribution is not influenced by hemodynamic changes, the effect of collateral flow on the hemodynamic dependencies related to stenosis resistance would thus be rather small. Consideration of Pb is also important for the interpretation of FFR measurements regarding collateral flow. In the presence of collateral flow, myocardial FFR (Eq. 5) progressively exceeds Qs/Qn with increasing stenosis severity (36), thus correctly reflecting the addition of collateral flow to total flow to the myocardium. As shown in this study, an elevated Pb has the same effect, when FFR is calculated assuming that Pb is zero (Eq. 6). In that case, however, it represents an overestimation of total myocardial perfusion and of the collateral flow contribution. Finally, it should be considered that by crossing the stenosis, the pressure-monitoring catheter or guide wire contributes to the measured pressure gradient (9, 23). This contribution was shown to be dependent on the ratio of catheter-to-lumen diameter and to be relatively small for the ultrathin guide wires used today, especially if the wire is located eccentrically within the lumen (1). The analysis of our model would still hold because an increased stenosis resistance caused by the presence of a catheter would decrease both FFR and Qs/Qn to the same degree, as was shown by the excellent correlations obtained in animals with a pressure wire crossing the stenosis (36). However, one should realize that the hemodynamic effect of a stenosis may be markedly overestimated in clinical practice once the ratio of catheter-to-lumen diameter exceeds 0.4 (23), which translates into a 70% diameter stenosis for a 0.035-mm guide wire in a 3-mm vessel.Clinical implications. FFR has been shown repeatedly to identify functionally relevant stenoses based on a cutoff value of 0.75, in both patients with normal ventricular function and patients with prior myocardial infarction, and our results do not refute its clinical usefulness. However, stenosis and coronary microvascular resistances are critical determinants of the value of FFR at the time of measurement. Limits of agreement between FFR and coronary flow velocity reserve caused by variability of microvascular resistance and the important role of stenosis resistance have been demonstrated by recent studies by our group (28-30). A gray zone around the cutoff value of 0.75 for clinical decision-making should therefore be appreciated, which is determined by the acute hemodynamic status of the patient (17). Moreover, our data demonstrate the risk of underestimating the contribution of a stenosis to a reduction in maximal blood flow, or of overestimating the fractional contribution of collateral flow, when Pb is assumed to be zero.
In conclusion, although FFR correctly represents the maximal flow ratio Qs/Qn if Pb is included in the calculation, its absolute value depends on hemodynamic conditions at the time of measurement, and FFR therefore cannot be considered a specific index for the epicardial stenosis alone. For intermediate lesions, which are not only close to the clinically used cutoff value but also more affected by hemodynamic changes than mild or severe lesions, the same stenosis can have an FFR above or below the cutoff value at different hemodynamic conditions. It is important to realize that both pressure- and flow-based indexes of flow reserve are a function of stenosis resistance and myocardial bed resistance, which vary as a consequence of variable hemodynamic conditions.| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by Grant 2000.090 of The Netherlands Heart Foundation.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. Siebes, Dept. of Cardiology B2-223, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands (E-mail: m.siebes{at}amc.uva.nl).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
May 23, 2002;10.1152/ajpheart.00165.2002
Received 27 February 2002; accepted in final form 20 May 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Back, LH.
Estimated mean flow resistance increase during coronary artery catheterization.
J Biomech
27:
169-175,
1994[ISI][Medline].
2.
Bartunek, J,
Sys SU,
Heyndrickx GR,
Pijls NH,
and
De Bruyne B.
Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort.
J Am Coll Cardiol
26:
328-334,
1995[Abstract].
3.
Bellamy, RF.
Calculation of coronary vascular resistance.
Cardiovasc Res
14:
261-269,
1980[ISI][Medline].
4.
Bellamy, RF,
and
O'Benar JD.
The determinants of the pressure-flow relation in the coronary vasculature.
J Biomech Eng
107:
41-45,
1985[ISI][Medline].
5.
Camici, PG,
Gistri R,
Lorenzoni R,
Sorace O,
Michelassi C,
Bongiorni MG,
Salvadori PA,
and
L'Abbate A.
Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms.
Circulation
86:
179-186,
1992
6.
Chamuleau, SAJ,
Meuwissen M,
van Eck-Smit BLF,
Koch KT,
de Jong A,
de Winter RJ,
Schotborgh CE,
Bax M,
Verberne HJ,
Tijssen JGP,
and
Piek JJ.
Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease.
J Am Coll Cardiol
37:
1316-1322,
2001
7.
Chareonthaitawee, P,
Kaufmann PA,
Rimoldi O,
and
Camici PG.
Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.
Cardiovasc Res
50:
151-161,
2001
8.
De Bruyne, B,
Bartunek J,
Sys SU,
Pijls NH,
Heyndrickx G,
and
Wijns W.
Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve.
Circulation
94:
1842-1849,
1996
9.
De Bruyne, B,
Pijls NH,
Paulus WJ,
Vantrimpont PJ,
Sys SU,
and
Heyndrickx GR.
Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire.
J Am Coll Cardiol
22:
119-126,
1993[Abstract].
10.
Di Carli, M,
Czernin J,
Hoh CK,
Gerbaudo VH,
Brunken RC,
Huang SC,
Phelps ME,
and
Schelbert HR.
Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease.
Circulation
91:
1944-1951,
1995
11.
Duncker, DJ,
and
Bache RJ.
Effect of chronotropic and inotropic stimulation on the coronary pressure-flow relation in left ventricular hypertrophy.
Basic Res Cardiol
92:
271-286,
1997[ISI][Medline].
12.
Duncker, DJ,
Zhang J,
Pavek TJ,
Crampton MJ,
and
Bache RJ.
Effect of exercise on coronary pressure-flow relationship in hypertrophied left ventricle.
Am J Physiol Heart Circ Physiol
269:
H271-H281,
1995
13.
Gewirtz, H.
Fractional flow reserve.
Circulation
94:
2306-2307,
1996.
14.
Gould, KL.
Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation.
Circ Res
43:
242-253,
1978
15.
Gould, KL,
Kirkeeide RL,
and
Buchi M.
Coronary flow reserve as a physiologic measure of stenosis severity.
J Am Coll Cardiol
15:
459-474,
1990[Abstract].
16.
Hanley, FL,
Messina LM,
Grattan MT,
and
Hoffman JIE
The effect of coronary inflow pressure on coronary vascular resistance in the isolated dog heart.
Circ Res
54:
760-772,
1984
17.
Hoffman, JIE
Problems of coronary flow reserve.
Ann Biomed Eng
28:
884-896,
2000[ISI][Medline].
18.
Hoffman, JIE,
and
Spaan JAE
Pressure-flow relations in coronary circulation.
Physiol Rev
70:
331-390,
1990
19.
Jeremy, RW,
Hughes CF,
and
Fletcher PJ.
Effects of left ventricular diastolic pressure on the pressure-flow relation of the coronary circulation during physiological vasodilation.
Cardiovasc Res
20:
922-930,
1986[ISI][Medline].
20.
Kirkeeide, RL.
Coronary obstructions, morphology and physiologic significance.
In: Quantitative Coronary Arteriography, edited by Reiber JHC,
and Serruys PW.. Dordrecht, The Netherlands: Kluwer Academic, 1991, p. 229-244.
21.
Klocke, FJ,
Mates RE,
Canty JM, Jr,
and
Ellis AK.
Coronary pressure-flow relationships. Controversial issues and probable implications.
Circ Res
56:
310-323,
1985
22.
L'Abbate, A,
Sambuceti G,
Haunso S,
and
Schneider-Eicke J.
Methods for evaluating coronary microvasculature in humans.
Eur Heart J
20:
1300-1313,
1999
23.
Leiboff, R,
Bren G,
Katz R,
Korkegi R,
and
Ross A.
Determinants of transstenotic gradients observed during angioplasty: an experimental model.
Am J Cardiol
52:
1311-1317,
1983[ISI][Medline].
24.
Logan, SE.
On the fluid mechanics of human coronary artery stenosis.
IEEE Trans Biomed Eng
22:
327-334,
1975[Medline].
25.
Marzilli, M,
Sambuceti G,
Fedele S,
and
L'Abbate A.
Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina.
J Am Coll Cardiol
35:
327-334,
2000
26.
Mates, RE,
Gupta RL,
Bell AC,
and
Klocke FJ.
Fluid dynamics of coronary artery stenosis.
Circ Res
42:
152-162,
1978
27.
Matthys, K,
Carlier S,
Segers P,
Ligthart J,
Sianos G,
Serrano P,
Verdonck PR,
and
Serruys PW.
In vitro study of FFR, QCA, and IVUS for the assessment of optimal stent deployment.
Catheter Cardiovasc Interv
54:
363-375,
2001[ISI][Medline].
28.
Meuwissen, M,
Chamuleau SAJ,
Siebes M,
Schotborgh CE,
Koch KT,
de Winter RJ,
Bax M,
de Jong A,
Spaan JAE,
and
Piek JJ.
Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions.
Circulation
103:
184-187,
2001
29.
Meuwissen, M,
Siebes M,
Chamuleau SAJ,
van Eck-Smit BLF,
Koch KT,
de Winter RJ,
Tijssen JGP,
Spaan JAE,
and
Piek JJ.
Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity.
Circulation
106:
441-446,
2002
30.
Meuwissen, M,
Siebes M,
Spaan JAE,
and
Piek JJ.
Rationale of combined intracoronary pressure and flow velocity measurements.
Z Kardiol
91, Suppl 3:
III108-III112,
2002.
31.
Panteley, GA,
Ladley HD,
and
Bristow JD.
Low zero-flow pressure and minimal capacitance effect on diastolic coronary arterial pressure-flow relationships during maximum vasodilation in swine.
Circulation
70:
485-494,
1984
32.
Pijls, NHJ,
and
De Bruyne B.
Coronary pressure measurement and fractional flow reserve.
Heart
80:
539-542,
1998
33.
Pijls, NHJ,
De Bruyne B,
Peels K,
van der Voort PH,
Bonnier HJRM,
Bartunek J,
and
Koolen JJ.
Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses.
N Engl J Med
334:
1703-1708,
1996
34.
Pijls, NHJ,
Kern MJ,
Yock PG,
and
De Bruyne B.
Practice and potential pitfalls of coronary pressure measurement.
Catheter Cardiovasc Interv
49:
1-16,
2000[ISI][Medline].
35.
Pijls, NHJ,
Van Gelder B,
Van der Voort P,
Peels K,
Bracke FALE,
Bonnier HJRM,
and
el Gamal MIH
Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow.
Circulation
92:
3183-3193,
1995
36.
Pijls, NHJ,
van Son JA,
Kirkeeide RL,
De Bruyne B,
and
Gould KL.
Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty.
Circulation
87:
1354-1367,
1993
37.
Sambuceti, G,
Marzilli M,
Fedele S,
Marini C,
and
L'Abbate A.
Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty.
Circulation
103:
2352-2345,
2001
38.
Segers, P,
Fostier G,
Neckebroeck J,
and
Verdonck P.
Assessing coronary artery stenosis severity: in vitro validation of the concept of fractional flow reserve.
Catheter Cardiovasc Interv
46:
375-379,
1999[ISI][Medline].
39.
Seiler, C,
Fleisch M,
Billinger M,
and
Meier B.
Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease.
J Am Coll Cardiol
34:
1985-1994,
1999
40.
Serruys, PW,
Di Mario C,
Meneveau N,
de Jaegere P,
Strikwerda S,
de Feyter PJ,
and
Emanuelsson H.
Intracoronary pressure and flow velocity with sensor-tip guidewires: a new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions.
Am J Cardiol
71:
41D-53D,
1993[Medline].
41.
Shipley, RE,
and
Gregg DE.
The effect of external constriction of a blood vessel on blood flow.
Am J Physiol
141:
289-296,
1944
42.
Siebes, M,
D'Argenio DZ,
and
Campbell CS.
Fluid dynamics of a partially collapsible stenosis in a flow model of the coronary circulation.
J Biomech Eng
118:
489-497,
1996[ISI][Medline].
43.
Siebes, M,
D'Argenio DZ,
and
Selzer RH.
Computer assessment of hemodynamic severity of coronary artery stenosis from angiograms.
Comput Methods Programs Biomed
21:
143-152,
1985[ISI][Medline].
44.
Siebes, M,
Vergroesen I,
van Liebergen RAM,
Meuwissen M,
and
Spaan JAE
Effect of changes in coronary resistance on fractional flow reserve (Abstract).
Circulation
102:
II-257,
2000.
45.
Spaan, JAE
Coronary Blood Flow. Mechanics, Distribution, and Control. Dordrecht, The Netherlands: Kluwer, 1991, p. 14-16, 166-168.
46.
Spaan, JAE,
Cornelissen AJM,
Chan C,
Dankelman J,
and
Yin FC.
Dynamics of flow, resistance, and intramural vascular volume in canine coronary circulation.
Am J Physiol Heart Circ Physiol
278:
H383-H403,
2000
47.
Uren, NG,
Crake T,
Lefroy DC,
de Silva R,
Davies GJ,
and
Maseri A.
Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction.
N Engl J Med
331:
222-227,
1994
48.
Uren, NG,
Melin JA,
De Bruyne B,
Wijns W,
Baudhuin T,
and
Camici PG.
Relation between myocardial blood flow and the severity of coronary-artery stenosis.
N Engl J Med
330:
1782-1788,
1994
49.
Young, DF.
Fluid mechanics of arterial stenoses.
J Biomech Eng
101:
157-175,
1979.
50.
Young, DF,
Cholvin NR,
Kirkeeide RL,
and
Roth AC.
Hemodynamics of arterial stenoses at elevated flow rates.
Circ Res
41:
99-107,
1977
This article has been cited by other articles:
![]() |
H. J. Verberne, M. Meuwissen, S. A. J. Chamuleau, B.-J. Verhoeff, B. L. F. van Eck-Smit, J. A. E. Spaan, J. J. Piek, and M. Siebes Effect of simultaneous intracoronary guidewires on the predictive accuracy of functional parameters of coronary lesion severity Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2349 - H2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev, October 1, 2006; 86(4): 1263 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-J. Verhoeff, M. Siebes, M. Meuwissen, B. Atasever, M. Voskuil, R. J. de Winter, K. T. Koch, J. G.P. Tijssen, J. A.E. Spaan, and J. J. Piek Influence of Percutaneous Coronary Intervention on Coronary Microvascular Resistance Index Circulation, January 4, 2005; 111(1): 76 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogawa, T. Ohkubo, R. Fukazawa, M. Kamisago, Y. Kuramochi, Y. Uchikoba, E. Ikegami, M. Watanabe, and Y. Katsube Estimation of myocardial hemodynamics before and after intervention in children with kawasaki disease J. Am. Coll. Cardiol., February 18, 2004; 43(4): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Krams, F. J. Ten Cate, S. G. Carlier, A. F. W. van der Steen, and P. W. Serruys Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., February 18, 2004; 43(4): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siebes, B.-J. Verhoeff, M. Meuwissen, R. J. de Winter, J. A.E. Spaan, and J. J. Piek Single-Wire Pressure and Flow Velocity Measurement to Quantify Coronary Stenosis Hemodynamics and Effects of Percutaneous Interventions Circulation, February 17, 2004; 109(6): 756 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sato, H. Yaoita, K. Maehara, and Y. Maruyama Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H359 - H368. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||